Tag: NVX-208
NuvOx Pharma and University of Arkansas begin phase IB/II clinical stroke...
NuvOx Pharma has announced that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed...